Last week, brokerage firm UBS Securities also initiated a 'sell' call on Aurobindo Pharma, assigning it a price target of Rs ...

Hyderabad: Aurobindo Pharma Limited has announced that it has received final approval from the US Food & Drug Administration ...

Aurobindo Pharma's subsidiary Apitoria Pharma has received 10 observations from the USFDA for its API manufacturing facility ...

Aurobindo Pharma has also been granted competitive generic therapy designation for these Cephalexin Tablets, qualifying the ...

The USFDA has issued 10 observations to Aurobindo Pharma's API manufacturing unit in Telangana after a September 2024 ...

The Hyderabad-based pharmaceutical manufacturing company said the observations are of procedural in nature and will be ...

Zydus Lifesciences, Maruti Suzuki India, Dabur India, South Indian Bank, Allcargo Logistics, International Conveyors, NMDC, ...

Telangana: Aurobindo Pharma has announced that the United States Food and Drug Administration (US FDA) has issued ten ...

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Cephalexin Tablets USP, 250 mg and 500 mg, which is bioequivalent and ...

Sri Aurobindo highlighted that true unity cannot be achieved by force or uniformity but through a genuine psychological bond rooted in spiritual oneness. India’s diversity in languages and cultures ...

Aurobindo Pharma receives USFDA approval for Cephalexin tablets, expected to launch in Q3FY25 with CGT designation.

Aurobindo Pharma gains FDA approval for Cephalexin Tablets, bioequivalent to Keflet, with CGT designation and shared exclusivity.